Pumping breastmilk in bathrooms is common at health care conferences

Nearly 100 people reached out to STAT about our column on the difficulty of pumping breastmilk at the J.P. Morgan Healthcare Conference.

January 18, 2024 Check out STAT+

Sponsored By

Adobe Pumping breastmilk in bathrooms is a common, albeit unspoken, practice at health care conferences Nearly 100 people reached out to STAT about our column on the difficulty of pumping breastmilk at the J.P. Morgan Healthcare Conference. By Tara Bannow Could long Covid's signs of immune dysregulation in the blood lead to a diagnostic test? Scientists find high levels of proteins from the complement system disrupted in long Covid patients, raising hope for a diagnostic test. By Elizabeth Cooney STAT+ | CRISPR-edited pig liver from eGenesis passes first test in brain-dead human, researchers say The pig livers are intended as a bridge to buy critically ill patients time to get a human transplant or for their failing organ to recover. By Megan Molteni Sandy Huffaker for STAT Amid a dire nationwide therapist shortage, could lay counselors help close the gap? The shortage is exacerbated by strict licensing and advanced-degree requirements. Is it time to train non-professionals as lay counselors? By Grace Rubenstein STAT+ | Apple Watch pulse oximeter feature removed to comply with ban Apple will remove the blood oxygen measurement feature from its Apple Watch, the company announced Thursday. By Lizzy Lawrence Bernie Sanders proposes subpoenas of CEOs of J&J, Merck on drug prices Bernie Sanders is hoping to subpoena the CEOs of J&J and Merck to testify in Congress about high drug prices in a highly unusual step. By Rachel Cohrs Biotech layoffs, slumping stocks, and a 2024 preview We discuss a new biotech trend: Cash-rich startups are laying off employees and tweaking strategies amid a tough market for venture capital. By Damian Garde and Allison DeAngelis and Adam Feuerstein STAT+ | How digital therapeutics companies are improvising when insurance coverage isn't guaranteed Health insurers have been slow to cover novel digital therapeutics, forcing the companies behind them to improvise to stay in business. By Mario Aguilar

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser